Letter: the probability to predict HBV-specific CD8+ cell response derived from HLA-A2+ may not foresee the functional cure well in Asian off-therapy cohort-authors' reply

Aliment Pharmacol Ther. 2022 Oct;56(8):1312-1313. doi: 10.1111/apt.17212.

Authors

Julia Peña-Asensio¹, Henar Calvo², Joaquín Miquel², Eduardo Sanz-de-Villalobos², Alejandro González-Praetorius³, Miguel Torralba^{4

5}, Juan-Ramón Larrubia^{2

5}

Affiliations

¹ Department of Biology of Systems, University of Alcalá, Alcalá de Henares, Spain.
² Section of Gastroenterology, Guadalajara University Hospital, Guadalajara, Spain.
³ Section of Microbiology, Guadalajara University Hospital, Guadalajara, Spain.
⁴ Service of Internal Medicine, Guadalajara University Hospital, Guadalajara, Spain.
⁵ Department of Medicine & Medical Specialties, University of Alcalá, Alcalá de Henares, Spain.

PMID: 36168258
DOI: 10.1111/apt.17212

No abstract available

Publication types

Letter
Comment

MeSH terms

CD8-Positive T-Lymphocytes
Cohort Studies
HLA-A2 Antigen*
Hepatitis B virus* / genetics
Humans
Probability

Substances

HLA-A2 Antigen